{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:01:08Z","timestamp":1788303668538,"version":"build-2803163510"},"reference-count":16,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jtct.2026.01.021","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T16:58:21Z","timestamp":1769187501000},"page":"551.e1-551.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["World Marrow Donor Association Statement on the Use of Plerixafor in Healthy Donors"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6988-7306","authenticated-orcid":false,"given":"Tania","family":"Dexter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalinga","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra Mart\u00ednez","family":"Trillos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4016-0020","authenticated-orcid":false,"given":"Jes\u00fas Fernandez","family":"Sojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Lachance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eefke","family":"Van Eerden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2612-0724","authenticated-orcid":false,"given":"Mats","family":"Bengtsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Pollichieni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Michael","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1349-1094","authenticated-orcid":false,"given":"Thilo","family":"Mengling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Rieping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Anthias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8963-9232","authenticated-orcid":false,"given":"Alison","family":"Bemis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1599-1869","authenticated-orcid":false,"given":"Meghann","family":"Cody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jtct.2026.01.021_bib0001","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/trf.12383","article-title":"Addition of plerixafor for CD34+ cell mobilization in six healthy stem cell donors ensured satisfactory grafts for transplantation","volume":"54","author":"Hauge","year":"2014","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.jtct.2026.01.021_bib0002","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1182\/bloodadvances.2018027599","article-title":"Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells","volume":"3","author":"Chen","year":"2019","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.jtct.2026.01.021_bib0003","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41409-020-01053-4","article-title":"Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial","volume":"56","author":"H\u00f6lig","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2026.01.021_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2021.103052","article-title":"Addition of plerixafor to G-CSF in poor mobilizing healthy related donors overcame mobilization failure: An observational case series on behalf of the Grupo Espa\u00f1ol de Trasplante Hematopoy\u00e9tico (GETH)","volume":"60","author":"Cid","year":"2021","journal-title":"Transfus Apher Sci"},{"issue":"1","key":"10.1016\/j.jtct.2026.01.021_bib5","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/trf.15037","article-title":"The feasibility and efficacy of subcutaneous plerixafor for mobilization of peripheral blood stem cells in allogeneic HLA\u2013identical sibling donors: results of the HOVON\u2010107 study","volume":"59","author":"de Greef","year":"2019","journal-title":"Transfusion (Paris)"},{"issue":"5","key":"10.1016\/j.jtct.2026.01.021_bib6","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/trf.12429","article-title":"Partial engraftment following plerixafor rescue after failed sibling donor peripheral blood stem cell harvest","volume":"54","author":"Eyre","year":"2014","journal-title":"Transfusion (Paris)"},{"issue":"8","key":"10.1016\/j.jtct.2026.01.021_bib7","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1111\/trf.13059","article-title":"Plerixafor on demand in ten healthy family donors as a rescue strategy to achieve an adequate graft for stem cell transplantation","volume":"55","author":"Gattillo","year":"2015","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.jtct.2026.01.021_bib8","first-page":"1737","volume":"57","author":"Kuang","year":"2022"},{"issue":"6","key":"10.1016\/j.jtct.2026.01.021_bib9","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/vox.13266","article-title":"Efficacy and safety of a reduced dose of plerixafor in combination with granulocyte colony-stimulating factor in healthy haploidentical stem cell donors","volume":"117","author":"Kurnikova","year":"2022","journal-title":"Vox Sang"},{"key":"10.1016\/j.jtct.2026.01.021_bib10","series-title":"Transfusion and Apheresis Science","article-title":"Stem Cells mobilization and collection in allogeneic related and unrelated donors: a single center experience with focus on plerixafor","volume":"62","author":"Marcon","year":"2023"},{"issue":"5","key":"10.1016\/j.jtct.2026.01.021_bib11","first-page":"762","article-title":"Successful mobilization of PBSCs in a healthy volunteer donor by addition of plerixafor after failure of mobilization with G-CSF alone","volume":"46","author":"Neumann","year":"2011","journal-title":"BMT"},{"issue":"3","key":"10.1016\/j.jtct.2026.01.021_bib12","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3324\/haematol.2016.147132","article-title":"Effect of high-dose plerixafor on CD34+ cell mobilization in healthy stem cell donors: Results of a randomized crossover trial","volume":"102","author":"Pantin","year":"2017","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.jtct.2026.01.021_bib13","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-014-0240-z","article-title":"Mobilization of healthy donors with plerixafor affects the cellular composition of T-cell receptor (TCR)-\u03b1\u03b2\/CD19-depleted haploidentical stem cell grafts","volume":"12","author":"Rutella","year":"2014","journal-title":"J Transl Med"},{"issue":"19","key":"10.1016\/j.jtct.2026.01.021_bib14","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1182\/blood-2016-09-739722","article-title":"Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft","volume":"129","author":"Schroeder","year":"2017","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jtct.2026.01.021_bib15","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1111\/trf.13239","article-title":"Prediction of hematopoietic stem cell yield after mobilization with granulocyte\u2013colony\u2010stimulating factor in healthy unrelated donors","volume":"55","author":"Teipel","year":"2015","journal-title":"Transfusion (Paris)"},{"issue":"4","key":"10.1016\/j.jtct.2026.01.021_bib16","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/jca.21992","article-title":"Addition of plerixafor in poorly mobilized allogeneic stem cell donors","volume":"37","author":"Zhuang","year":"2022","journal-title":"J Clin Apher"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726000564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726000564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T11:08:27Z","timestamp":1780312107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726000564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2666636726000564"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.01.021","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"World Marrow Donor Association Statement on the Use of Plerixafor in Healthy Donors","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}